Gain-of-function polymorphisms of cystathionine β-synthase and delayed cerebral ischemia following aneurysmal subarachnoid hemorrhage: Clinical article

Journal of Neurosurgery

Volumn 115, Issue 1, 2011, Pages 101-107

  Grobelny, Bartosz T ^a   Ducruet, Andrew F ^b   Derosa, Peter A ^b   Kotchetkov, Ivan S ^b   Zacharia, Brad E ^b   Hickman, Zachary L ^b   Fernandez, Luis ^b   Narula, Reshma ^b   Claassen, Jan ^b   Lee, Kiwon ^b   Badjatia, Neeraj ^b   Mayer, Stephan A ^b   Connolly Jr , E Sander ^b  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

Cystathionine beta synthase; Delayed cerebral ischemia; Hydrogen sulfide; Subarachnoid hemorrhage; Vascular disorders; Vasospasm

Indexed keywords

CYSTATHIONINE BETA SYNTHASE; HOMOCYSTEINE; HYDROGEN SULFIDE;

ADULT; ARTICLE; BRAIN ANGIOGRAPHY; BRAIN ARTERY ANEURYSM; BRAIN ISCHEMIA; BRAIN VASOSPASM; CBS GENE; DNA EXTRACTION; DNA SEQUENCE; FEMALE; GENE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK REDUCTION; SIGNAL TRANSDUCTION; SUBARACHNOID HEMORRHAGE; VASODILATATION;

AGED; BRAIN ISCHEMIA; CYSTATHIONINE BETA-SYNTHASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HOMOCYSTEINE; HUMANS; HYDROGEN SULFIDE; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RISK FACTORS; SUBARACHNOID HEMORRHAGE; TIME FACTORS; VASOSPASM, INTRACRANIAL;

EID: 79959986202     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2011.2.JNS101414     Document Type: Article

References (29)

1. Abe K, Kimura H: The possible role of hydrogen sulfide as an endogenous neuromodulator. J Neurosci 16:1066-1071, 1996 (Pubitemid 26140863)
2. Dreier JP, Körner K, Ebert N, Görner A, Rubin I, Back T, et al: Nitric oxide scavenging by hemoglobin or nitric oxide synthase inhibition by N-nitro-L-arginine induces cortical spreading ischemia when K+ is increased in the subarachnoid space. J Cereb Blood Flow Metab 18:978-990, 1998 (Pubitemid 28427865)
3. Fredriksen A, Meyer K, Ueland PM, Vollset SE, Grotmol T, Schneede J: Large-scale population-based metabolic phenotyping of thirteen genetic polymorphisms related to one-carbon metabolism. Hum Mutat 28:856-865, 2007 (Pubitemid 47579935)
4. Frontera JA, Fernandez A, Schmidt JM, Claassen J, Wartenberg KE, Badjatia N, et al: Defining vasospasm after subarachnoid hemorrhage: what is the most clinically relevant definition? Stroke 40:1963-1968, 2009
5. Kawabata A, Ishiki T, Nagasawa K, Yoshida S, Maeda Y, Takahashi T, et al: Hydrogen sulfide as a novel nociceptive messenger. Pain 132:74-81, 2007 (Pubitemid 47494563)
6. Kreiter KT, Copeland D, Bernardini GL, Bates JE, Peery S, Claassen J, et al: Predictors of cognitive dysfunction after subarachnoid hemorrhage. Stroke 33:200-208, 2002 (Pubitemid 34052210)
7. Kruger WD, Evans AA, Wang L, Malinow MR, Duell PB, Anderson PH, et al: Polymorphisms in the CBS gene associated with decreased risk of coronary artery disease and increased responsiveness to total homocysteine lowering by folic acid. Mol Genet Metab 70:53-60, 2000 (Pubitemid 30396204)
8. Kumar M, Tyagi N, Moshal KS, Sen U, Kundu S, Mishra PK, et al: Homocysteine decreases blood flow to the brain due to vascular resistance in carotid artery. Neurochem Int 53:214-219, 2008
9. Lim MH, Cho YI, Jeong SK: Homocysteine and pulsatility index of cerebral arteries. Stroke 40:3216-3220, 2009
10. Lonn E, Yusuf S, Arnold MJ, Sheridan P, Pogue J, Micks M, et al: Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 354:1567-1577, 2006 [Erratum in N Engl J Med 355:746, 2006]
11. Macdonald RL, Kassell NF, Mayer S, Ruefenacht D, Schmiedek P, Weidauer S, et al: Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebocontrolled phase 2 dose-finding trial. Stroke 39:3015-3021, 2008
12. Minamishima S, Bougaki M, Sips PY, Yu JD, Minamishima YA, Elrod JW, et al: Hydrogen sulfide improves survival after cardiac arrest and cardiopulmonary resuscitation via a nitric oxide synthase 3-dependent mechanism in mice. Circulation 120:888-896, 2009
13. Neil-Dwyer G, Lang DA, Doshi B, Gerber CJ, Smith PW: Delayed cerebral ischaemia: the pathological substrate. Acta Neurochir (Wien) 131:137-145, 1994 (Pubitemid 24348142)
14. Petzold GC, Haack S, von Bohlen und Halbach O, Priller J, Lehmann TN, Heinemann U, et al: Nitric oxide modulates spreading depolarization threshold in the human and rodent cortex. Stroke 39:1292-1299, 2008 (Pubitemid 351440704)
15. Pfeiffer CM, Huff DL, Gunter EW: Rapid and accurate HPLC assay for plasma total homocysteine and cysteine in a clinical laboratory setting. Clin Chem 45:290-292, 1999 (Pubitemid 29079132)
16. Pluta RM, Hansen-Schwartz J, Dreier J, Vajkoczy P, Macdonald RL, Nishizawa S, et al: Cerebral vasospasm following subarachnoid hemorrhage: time for a new world of thought. Neurol Res 31:151-158, 2009
17. Qu K, Chen CPLH, Halliwell B, Moore PK, Wong PTH: Hydrogen sulfide is a mediator of cerebral ischemic damage. Stroke 37:889-893, 2006 (Pubitemid 43731927)
18. Seifert V, Löffler BM, Zimmermann M, Roux S, Stolke D: Endothelin concentrations in patients with aneurysmal subarachnoid hemorrhage. Correlation with cerebral vasospasm, delayed ischemic neurological deficits, and volume of hematoma. J Neurosurg 82:55-62, 1995
19. Sen U, Tyagi N, Kumar M, Moshal KS, Rodriguez WE, Tyagi SC: Cystathionine-beta-synthase gene transfer and 3-deazaadenosine ameliorate inflammatory response in endothelial cells. Am J Physiol Cell Physiol 293:C1779-C1787, 2007 (Pubitemid 350255073)
20. Silfa E, Almeida M, Cerda J, Wu S, López-Garriga J: Orientation of the heme vinyl groups in the hydrogen sulfide-binding hemoglobin I from Lucina pectinata. Biospectroscopy 4:311-326, 1998 (Pubitemid 128767595)
21. Sitdikova GF, Weiger TM, Hermann A: Hydrogen sulfide increases calcium-activated potassium (BK) channel activity of rat pituitary tumor cells. Pflügers Arch 459:389-397, 2010
22. Starke RM, Kim GH, Komotar RJ, Hickman ZL, Black EM, Rosales MB, et al: Endothelial nitric oxide synthase gene single-nucleotide polymorphism predicts cerebral vasospasm after aneurysmal subarachnoid hemorrhage. J Cereb Blood Flow Metab 28:1204-1211, 2008 (Pubitemid 351733342)
23. Stein SC, Browne KD, Chen XH, Smith DH, Graham DI: Thromboembolism and delayed cerebral ischemia after subarachnoid hemorrhage: an autopsy study. Neurosurgery 59:781-788, 2006
24. Tettenborn D, Dycka J: Prevention and treatment of delayed ischemic dysfunction in patients with aneurysmal subarachnoid hemorrhage. Stroke 21 (12 Suppl):IV85-IV89, 1990
25. Tettenborn D, Dycka J, Volberg E, Düdden P: Blood pressure and heart rate during treatment with nimodipine in patients with subarachnoid hemorrhage. Neurochirurgia (Stuttg) 28 (Suppl 1):84-86, 1985 (Pubitemid 15050412)
26. Toole JF, Malinow MR, Chambless LE, Spence JD, Pettigrew LC, Howard VJ, et al: Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 291:565-575, 2004 (Pubitemid 38500310)
27. Whitfield NL, Kreimier EL, Verdial FC, Skovgaard N, Olson KR: Reappraisal of H2S/sulfide concentration in vertebrate blood and its potential significance in ischemic preconditioning and vascular signaling. Am J Physiol Regul Integr Comp Physiol 294:R1930-R1937, 2008
28. Yang G, Wu L, Jiang B, Yang W, Qi J, Cao K, et al: H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science 322:587-590, 2008
29. Zhao W, Zhang J, Lu Y, Wang R: The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener. EMBO J 20:6008-6016, 2001 (Pubitemid 33049276)